Furthermore, increasing LAP values have been associated with atherogenic dyslipidemia (increased apoB levels, reduced LDL and HDL particle size) and insulin resistance [23], which in turn could lead to arterial stiffness [24] and possibly coronary atherosclerosis progression [25]. Here, APOB is linked to metabolic syndrome.